Foundation Medicine, Inc. is a biotechnology company that develops and sells genomic profiling assays based on next-generation sequencing technology. As of 2018, the company has one wholly owned subsidiary: Foundation Medicine, Europe Holding.Foundation Medicine was founded by Dr. Jay Flatley in 2011 and originally incorporated as Astellas Pharma US, Inc.. It was acquired by Foundation Medicine in 2013 with an estimated cost of $210 million. The company is privately held and has no listed shares of stock.
Founded on a strong foundation of collaboration and innovation, Foundation Medicine is a place where all ideas are welcome - encouraged. The work is challenging and stimulating, with new opportunities for growth frequently arising. As a remote company, you'll spend your days working from home and can advance at your own pace. Find out more about working at Foundation Med